Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 937591-69-0 | MDL No. : | MFCD09743046 |
Formula : | C14H19BO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RWJUUXWJBMIGKA-UHFFFAOYSA-N |
M.W : | 246.11 | Pubchem ID : | 16750469 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.57 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 72.26 |
TPSA : | 27.69 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.74 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.91 |
Log Po/w (WLOGP) : | 1.92 |
Log Po/w (MLOGP) : | 1.67 |
Log Po/w (SILICOS-IT) : | 2.38 |
Consensus Log Po/w : | 1.78 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.38 |
Solubility : | 0.103 mg/ml ; 0.000417 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.15 |
Solubility : | 0.173 mg/ml ; 0.000704 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.29 |
Solubility : | 0.0125 mg/ml ; 0.0000508 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.01 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51% | 5-(4,4,5,5-Tetramethyl[1,3,2]-dioxaborolan-2-yl)-2,3-dihydro-benzofuran The title compound, MS: m/e=246.1 (M') was obtained as a light yellow oil (51% yield) using 2,3-dihydro-5-iodobenzo[b]furan. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17% | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; caesium carbonate; In 1,2-dimethoxyethane; water; at 100℃; for 1.0h;Inert atmosphere; Sealed tube; | A pressure vessel is charged with 5-bromo-7-chloro-quinoxaline (Intermediate 2 (288 mg, 1 .18 mmol, 1 eq.), 5-(4,4,5,5-tetramethyl- [1 ,3,2]dioxaborolan-2-yl)-2,3-dihydrobenzofuran (306 mg; 1.18 mmol; 1 eq.), cesium carbonate (779 mg; 2.37 mmol; 2 eq.), 1 ,2-dimethoxyethane (10 mL) and water (5 mL). The reaction mixture is sparged with argon under sonication before Pd(dppf)Cl2*CH2CI2 (148 mg; 0.18 mmol; 0.15 eq.) is added. The tube is sealed and the reaction mixture is stirred at 100 C for 1 h. After coming back to room temperature, the reaction mixture is partitioned between EtOAc and water. The aq. layer is extracted with EtOAc and the combined organic layers are washed with water and brine, dried over Na2S04 filtered through a pad of celite and concentrated in vacuo. Purification of the residue by FCC (EtOAc gradient in hexane) affords 7- chloro-5-(2,3-dihydro-1-benzofuran-5-yl)quinoxaline (58 mg; 0.20 mmol; yield: 17%; off-white powder; UPLC purity: 97%) |
[ 445303-12-8 ]
2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.99
[ 754226-40-9 ]
2-(4-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.96
[ 765908-38-1 ]
2-(3-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.95
[ 1009303-77-8 ]
2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanol
Similarity: 0.92
[ 1002727-88-9 ]
2-(Chroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.91
[ 445303-12-8 ]
2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.99
[ 519054-55-8 ]
2-(Benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.91
[ 1192755-14-8 ]
2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.87
[ 227305-69-3 ]
2,3-Dihydrobenzofuran-5-boronic acid
Similarity: 0.77
[ 763120-44-1 ]
(2,3-Dihydrobenzofuran-6-yl)boronic acid
Similarity: 0.76